ING-1

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameING-1
Drug Alias NameING 1 antibodyING-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunostimulantsEpithelial cell adhesion molecule inhibitors
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXoma (Us) Llc
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksDrugBank